Answer
Clinical evidence showed more skin tumours in treated areas than with comparator treatment. The European review concluded that the risks outweighed the benefits.
Sources for this answer
- European Medicines AgencyEuropean Medicines Agency · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.